These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21803400)

  • 1. Stable expression of native Coagulation factor VIII using the 2A self-processing sequence and furin cleavage site.
    He B; Pan Y; Chen L; Xu Y; Chen N; Gu L; Nie Z; Wang S; Liu Z
    Thromb Res; 2011 Dec; 128(6):e148-53. PubMed ID: 21803400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.
    Nguyen GN; George LA; Siner JI; Davidson RJ; Zander CB; Zheng XL; Arruda VR; Camire RM; Sabatino DE
    J Thromb Haemost; 2017 Jan; 15(1):110-121. PubMed ID: 27749002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering of coagulation factor VIII for improved secretion.
    Miao HZ; Sirachainan N; Palmer L; Kucab P; Cunningham MA; Kaufman RJ; Pipe SW
    Blood; 2004 May; 103(9):3412-9. PubMed ID: 14726380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced plasma factor VIII activity in mice via cysteine mutation using dual vectors.
    Zhu F; Liu Z; Miao J; Qu H; Chi X
    Sci China Life Sci; 2012 Jun; 55(6):521-6. PubMed ID: 22744182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.
    Demasi MA; de S Molina E; Bowman-Colin C; Lojudice FH; Muras A; Sogayar MC
    Mol Biotechnol; 2016 Jun; 58(6):404-14. PubMed ID: 27126696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.
    Siner JI; Samelson-Jones BJ; Crudele JM; French RA; Lee BJ; Zhou S; Merricks E; Raymer R; Nichols TC; Camire RM; Arruda VR
    JCI Insight; 2016 Oct; 1(16):e89371. PubMed ID: 27734034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retroviral-mediated high efficient in vitro expression of human coagulation factor VIII].
    Guo X; Wang H; Chu H; Wang X; Qu B; Li Z; Qi Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):457-9. PubMed ID: 11877017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetics of hemophilia A].
    De Brasi CD; Slavutsky IR; Larripa IB
    Medicina (B Aires); 1996; 56(5 Pt 1):509-17. PubMed ID: 9239887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice.
    Connelly S; Andrews JL; Gallo-Penn AM; Tagliavacca L; Kaufman RJ; Kaleko M
    Thromb Haemost; 1999 Feb; 81(2):234-9. PubMed ID: 10063998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
    Liu L; Mah C; Fletcher BS
    Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII can be synthesized in hemophilia A mice liver by bone marrow progenitor cell-derived hepatocytes and sinusoidal endothelial cells.
    Yadav N; Kanjirakkuzhiyil S; Ramakrishnan M; Das TK; Mukhopadhyay A
    Stem Cells Dev; 2012 Jan; 21(1):110-20. PubMed ID: 21480781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation factors with improved properties for hemophilia gene therapy.
    Pipe SW
    Semin Thromb Hemost; 2004 Apr; 30(2):227-37. PubMed ID: 15118934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles of the factor VIII B domain.
    Pipe SW
    Haemophilia; 2009 Nov; 15(6):1187-96. PubMed ID: 19473417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of factor VII by muscle cells in vitro and in vivo following direct gene transfer: modelling gene therapy for haemophilia.
    Miller G; Steinbrecher RA; Murdock PJ; Tuddenham EG; Lee CA; Pasi KJ; Goldspink G
    Gene Ther; 1995 Dec; 2(10):736-42. PubMed ID: 8750013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic pigs produce functional human factor VIII in milk.
    Paleyanda RK; Velander WH; Lee TK; Scandella DH; Gwazdauskas FC; Knight JW; Hoyer LW; Drohan WN; Lubon H
    Nat Biotechnol; 1997 Oct; 15(10):971-5. PubMed ID: 9335047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional factor VIII made with von Willebrand factor at high levels in transgenic milk.
    Pipe SW; Miao H; Butler SP; Calcaterra J; Velander WH
    J Thromb Haemost; 2011 Nov; 9(11):2235-42. PubMed ID: 21920013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-domain deleted factor VIII is aggregated and degraded through proteasomal and lysosomal pathways.
    Plantier JL; Guillet B; Ducasse C; Enjolras N; Rodriguez MH; Rolli V; Négrier C
    Thromb Haemost; 2005 May; 93(5):824-32. PubMed ID: 15886795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the 2A/furin technology with an animal component free cell line development platform process.
    Jostock T; Dragic Z; Fang J; Jooss K; Wilms B; Knopf HP
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1517-24. PubMed ID: 20461511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.